KRH-3955结构式
|
常用名 | KRH-3955 | 英文名 | KRH-3955 |
|---|---|---|---|---|
| CAS号 | 1097732-62-1 | 分子量 | 929.964 | |
| 密度 | N/A | 沸点 | N/A | |
| 分子式 | C40H63N7O18 | 熔点 | N/A | |
| MSDS | N/A | 闪点 | N/A |
KRH-3955用途A potent, selective, orally bioavailable inhibitor of CXCR4 that efficiently inhibits SDF-1α binding to CXCR4 with IC50 of 0.61 nM. |
| 英文名 | KRH-3955 |
|---|---|
| 英文别名 | 更多 |
| 分子式 | C40H63N7O18 |
|---|---|
| 分子量 | 929.964 |
| 精确质量 | 929.422974 |
| InChIKey | PVKNAUJEVORNRR-NOKJQLKVSA-N |
| SMILES | CCCN(CCC)CCCCN(C)Cc1ccc(CN(Cc2ncc[nH]2)Cc2nccn2C)cc1.O=C(O)C(O)C(O)C(=O)O.O=C(O)C(O)C(O)C(=O)O.O=C(O)C(O)C(O)C(=O)O |
| Butanedioic acid, 2,3-dihydroxy-, (2R,3R)-, compd. with N1-[4-(dipropylamino)butyl]-N4-(1H-imidazol-2-ylmethyl)-N1-methyl-N4-[(1-methyl-1H-imidazol-2-yl)methyl]-1,4-benzenedimethanamine (3:1) |
| KRH-3955 |
| (2R,3R)-2,3-Dihydroxysuccinic acid - N-[4-({(1H-imidazol-2-ylmethyl)[(1-methyl-1H-imidazol-2-yl)methyl]amino}methyl)benzyl]-N-methyl-N',N'-dipropyl-1,4-butanediamine (3:1) |
| SF655E80Z8 |